FROM Dan Burk
Genetic Breakthroughs: Patents and Profits Mapping the human genome began "the biological gold rush of the 21st Century," with companies now owning patents on 4000 human genes. Today, the US Supreme Court is being asked to strike down two patents on BRCA 1 and BRCA 2, genes that helped doctors discover both breast and ovarian cancer. Nobody can do that without paying Myriad Genetics , which isolated the genes. But opponents argue the genes are "products of Nature." We hear about a case with long-term implications for the future of "personalized medicine" designed to serve the needs of each individual patient.
America's top diplomat faces challenges in Asia Whatever happened to America's "pivot to Asia?" That's just one of the questions left hanging since Rex Tillerson's first trip there as Secretary of State. Is the Trump Administration hoping to change Foreign Policy or maintain the status quo?
Getting answers on phone taps, Russia and leaking The Directors of the FBI and the NSA testified on Capitol Hill today there's no evidence for President Trump's claim he was wire-tapped by former President Obama. We'll hear about that and the investigation into Russian tampering with last year's presidential campaign.
Trump's travel ban and the long-term agenda The Trump Administration's revised travel ban may be good news for some visa holders and others, but it's still being challenged as unconstitutional. Some reporters call it the beginning of a long-term effort to change the demographic make-up of the United States.
Political appointments and the reshaping of the judiciary President Trump has the chance for a long-term impact -- not just on the US Supreme Court, but on the entire federal court system. And his nominees are likely to get the support of a massive spending campaign by donors who don't have to reveal their names. Can President Trump "pack" the federal court system?